Delivery Order SPE2DB25D3018-SPE2DB25FUXKM
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Envarsus XR 4 mg tablets, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $2,356.57 and is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award, valued at $1,718.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Envarsus XR 1 mg tablets, a medication used to prevent organ rejection in kidney transplant patients. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 29, 2025. It is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 0.75 mg tablets, a medication used for transplant patients. The contract has a ceiling value of $1,289.24 and a period of performance through May 19, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Envarsus XR 1 mg tablets, a medication used for transplant patients. The contract has a ceiling value of $5,307.45 and runs through March 5, 2025. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Envarsus XR 4 mg tablets, a medication used for transplant patients. The contract has a firm fixed price of $5,135.85 and a completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business category. The award is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,261.28 firm-fixed-price contract is for the supply of the medication Envarsus XR 4 mg tablet, a treatment for organ transplant patients. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $1,216.11 and runs through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 4 mg tablets. The contract has a ceiling value of $1,711.95 and a period of performance through April 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Envarsus XR 1 mg tablets, a prescription medication, to DLA facilities. The contract has a ceiling value of $1,216.11 and a period of performance ending on April 16, 2024. Amerisourcebergen is the prime contractor, and the contract was awarded on a full and open competition basis without any set-aside...
This is a $1,169.76 delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Envarsus XR 0.75 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 16, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...